(Q56996659)
Statements
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia (English)
0 references
15 December 2006
0 references
12
0 references
7374-9
0 references
24
0 references